Skip to main content

MARSHALL WACE, LLP

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in FDMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$283,848
+$128,111 QoQ
Shares Held
21,342
+27.6% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 158 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in FDMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. FDMT ranks #235 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FDMT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $283,848 21,342
2026-03-31 $155,737 16,728
2025-12-31 $208,185 27,758
2025-09-30 $1,267,931 145,907
2025-06-30 $955,769 257,620
2025-03-31 $511,270 158,288
2024-12-31 $293,784 52,744
2024-09-30 $1,785,736 165,193
2024-06-30 $3,901,327 185,866
2024-03-31 $8,211,787 257,746
2023-03-31 $583,669 33,954
2022-12-31 $1,549,080 69,747
2021-12-31 $72,774 3,317
2021-03-31 $813,808 18,760
2020-12-31 $308,222 7,436